Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

556results about How to "Reduce and prevent" patented technology

Compact oronasal patient interface

A breathing arrangement includes a patient interface, at least one inlet conduit, and a headgear assembly. The patient interface includes a mouth covering assembly including a cushion structured to sealingly engage around exterior of a patient's mouth in use, a nozzle assembly including a pair of nozzles structured to sealingly engage within nasal passages of a patient's nose in use, and a flexible element connecting the mouth covering assembly and the nozzle assembly. The at least one inlet conduit is structured to deliver breathable gas into at least one of the mouth covering assembly and the nozzle assembly for breathing by the patient. The headgear assembly is removably connected to at least one of the mouth covering assembly and the nozzle assembly so as to maintain the mouth covering assembly and the nozzle assembly in a desired position on the patient's face.
Owner:RESMED LTD

Compact oronasal patient interface

ActiveUS20060237017A1Prevents and reduces mouth leakComfortable and effective interfaceRespiratory masksBreathing masksNasal passageNasal passages
A breathing arrangement includes a patient interface, at least one inlet conduit, and a headgear assembly. The patient interface includes a mouth covering assembly including a cushion structured to sealingly engage around exterior of a patient's mouth in use, a nozzle assembly including a pair of nozzles structured to sealingly engage within nasal passages of a patient's nose in use, and an element connecting the mouth covering assembly and the nozzle assembly. The at least one inlet conduit is structured to deliver breathable gas into at least one of the mouth covering assembly and the nozzle assembly for breathing by the patient. The headgear assembly is removably connected to at least one of the mouth covering assembly and the nozzle assembly so as to maintain the mouth covering assembly and the nozzle assembly in a desired position on the patient's face.
Owner:RESMED LTD

System and method for retail store shelf stock monitoring, predicting, and reporting

InactiveUS20100138281A1Increase store sale profitPreventing and reducing sale lossHand manipulated computer devicesPayment architectureVisual presentationEngineering
A system for retail store shelf stock status monitoring, predicting, and reporting that is capable of monitoring retail store current shelf stock capacity and shelf product freshness at product level, category level, department level, store level, and other product hierarchy levels. It is also capable of intelligently predicting future shelf stock status according to predicted future store sales activities. It uses shelf stock empty index, out-of-stock alert, shelf stock freshness, shelf stock expiration alert, and other shelf stock performance measures to present current shelf status, future shelf status, and past shelf stock performances through interactive store maps and other visual presentation means to optimally deliver retail store shelf stock performance information in real time. The system empowers store clerks, store managers, chain store management, and corporation analysts to monitor, review, and analyze store shelf stock status in real time from anywhere at any time.
Owner:ZHANG YINYING +1

System and method for providing database security measures

InactiveUS20060032909A1Increases arrest rateIncrease in arrest rateFinancePayment circuitsDatabase securityCard reader
A trigger card and system for preventing credit and debit card fraud is disclosed. The trigger card is adapted to be indistinguishable from typical credit cards and other cards issued by financial institutions. The system is adapted to receive signals when a standard card reader reads the trigger card. The system is further adapted to initiate an automated procedure to reduce fraud upon receipt of the signal indicating that the trigger card has been read by the card reader.
Owner:SEEGAR MARK

Treatment of leg ulcers using placenta derived collagen biofabric

The present invention provides a method of treating a leg ulcer comprising contacting the leg ulcer with a collagen biofabric. The leg ulcer may be a venous, arterial, diabetic or decubitus (pressure) ulcer. The invention further provides kits comprising one or more pieces of collagen biofabric for the treatment of a leg ulcer.
Owner:CELULARITY INC

Subsea chemical injection unit for additive injection and monitoring system for oilfield operations

InactiveUS7234524B2Reduce and prevent such buildupPromote of formationDrilling rodsCleaning apparatusOcean bottomMonitoring system
A system monitors and controls the injection of additives into formation fluids recovered through a subsea well. The system includes a chemical injection unit and a controller positioned at a remote subsea location. The injection unit uses a pump to supply one or more selected additives from a subsea and / or remote supply unit. The controller operates the pump to control the additive flow rate based on signals provided by sensors measuring a parameter of interest. A one mode system includes a surface facility for supporting the subsea chemical injection and monitoring activities. In one embodiment, the surface facility is an offshore rig that provides power and has a chemical supply that provides additives to one or more injection units. In another embodiment, the surface facility includes a relatively stationary buoy and a mobile service vessel. When needed, the service vessel transfers additives to the chemical injection units via the buoy.
Owner:BAKER HUGHES INC

Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia

InactiveUS6991804B2Preventing and reducing intimal hyperplasiaPrevent and reduce intimal hyperplasiaOrganic active ingredientsAerosol deliveryIntimal proliferationPercent Diameter Stenosis
The invention provides methods for treating injuries to one or more internal structures of a subject by administering a drug delivery vehicle to an external surface of the injured structure. The drug delivery vehicle substantially adheres to the site of administration and provides for the release of a bioactive agent that reduces or prevents further injury to the internal structure by disease processes, such as hyperplasia.
Owner:EDWARDS LIFESCIENCES CORP

Optical coupler for use in an optical touch sensitive device

An optical touch-sensitive device is able to determine the locations of multiple simultaneous touch events. The optical touch-sensitive device includes multiple emitters and detectors coupled with an optical coupler assembly through a waveguide on the surface on the optical-touch sensitive device. The coupler may be side coupled or edge coupled to the waveguide. For both the side coupled or edge coupled cases, the coupler may also be configured to reorient beams to accommodate any orientation of emitters and detectors with respect to the waveguide. The coupler may also be configured to translate beams laterally or vertically to accommodate any position of emitters and detectors. The coupler, and touch-sensitive device more generally, are also configured to prevent ambient light entering the waveguide from hitting the emitters and detectors. Each emitter produces optical beams which are received by the detectors. Touch events disturb the optical beams.
Owner:BEECHROCK LTD

Ureteral stent with end-effector and related methods

InactiveUS6949125B2Decreased fluid retentionMinimizing patient discomfortBalloon catheterSurgeryUrethraControl release
A system and related methods for maintaining the patentcy of the ureter comprising a pusher tube having a pusher tube lumen and an inflate lumen disposed within a wall of the pusher tube and a urinary stent having a proximal and distal portions with an elongated body portion therebetween configured to fit the ureter of the patient and defining a lumen. The system further includes an end-effector that may comprise an inflatable balloon positioned at the proximal portion of the urinary stent for retaining the proximal portion in the urinary bladder. At the distal portion, a retention end-piece is positioned for retaining the distal portion of the stent in the renal pelvis. The end-effector and the retention end-piece of the stent maintain the elongated body portion in situ. The end-effector may also include an inflatable balloon and may contain pharmaceutical or biologic agents for controlled release into the bladder.
Owner:BOSTON SCI SCIMED INC

Sleep appliance

A dental oral appliance to reduce or eliminate snoring or obstructive sleep apnea and to open the airway for a sleeping patient. The appliance covers the inside (lingual) of the upper or lower teeth and has an open palate. Retention for the appliance is provided by an occlusal coverge of the upper or lower teeth. A raised incisor ramp that extends from the incisal tip of the incisors toward the lingual, or posterior ramps, separate the posterior teeth to open the airway. A transpalatal bar, which extends from the inside (lingual) of the right molars to the inside of the left molars, inhibits the upward and backward movement of the tongue. An anterior tongue restrainer which is attached to the transpalatal bar at one end and the front of the appliance at the other end, aids in inhibiting and restraining the upward and backward movement of the tongue.
Owner:FULL BREATH

Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes

ActiveUS20100178276A1Prevent metastasisPrevent occurrence and recurrenceAntibacterial agentsAntimycoticsT cellT lymphocyte
The present invention provides immunoresponsive cells, including T cells, cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells, expressing at least one of an antigen-recognizing receptor and a co-stimulatory ligand and methods of use therefore for the treatment of neoplasia and other pathologies where an increase in an antigen-specific immune response is desired.
Owner:MEMORIAL SLOAN KETTERING CANCER CENT

Catalytic converter for cleaning exhaust gas

A catalytic converter for cleaning exhaust gas includes a heat-resistant support, and a catalytic coating formed on the heat-resistant support. The catalytic coating contains Pd-carrying particles of a cerium complex oxide, Pt & Rh-carrying particles of zirconium complex oxide, and particles of a heat-resistant inorganic oxide.
Owner:DAIHATSU MOTOR CO LTD +1

Use of PEO-PBO block copolymers in ophthalmic compositions

The use of poly(oxyethylene)-poly(oxybutylene) block copolymers in pharmaceutical compositions useful for modifying the surfaces of contact lenses and other medical devices is disclosed. The present invention is based in-part on a discovery that this class of compounds is particularly efficient in wetting hydrophobic surfaces, such as the surfaces of silicone hydrogel contact lenses and other types of ophthalmic lenses. Such compounds are also useful for cleaning purposes. The use of the compounds as surfactants in various types of compositions for treating contact lenses therefore represents a preferred embodiment of the present invention.
Owner:ALCON INC

Anatomically-orientated and self-positioning transcatheter mitral valve

ActiveUS20160206424A1Easy to conformEasily orientBalloon catheterHeart valvesMitral valve stenosisParavalvular leak
Described herein is a mitral valve and systems and methods for implanting the same. The mitral valve device is designed to easily orient to and conform to the mitral orifice natural morphology. This mitral valve system may be implanted using a system of 2 guide wires that facilitate orientation of the flat portion of the stent properly with the flat portion of the mitral valve that is adjacent to the aortic valve. Additionally, the disclosed valve may have multiple mounds distributed across the outer surface of the valve / stent complex so as to prevent or reduce paravalvular leak after implantation.
Owner:CEDARS SINAI MEDICAL CENT

Organic light emitting diode display

An organic light emitting diode display according to an example embodiment of the present invention includes: a substrate; a scan line and a data line that are insulated from one another and crossing each other on the substrate; a first transistor on the substrate and connected to the scan line and the data line; a second transistor connected to the first transistor; a first electrode connected to the second transistor and having a cutout; an organic emission layer on the first electrode; and a second electrode on the organic emission layer, wherein the cutout is at a position corresponding to the data line.
Owner:SAMSUNG DISPLAY CO LTD

Oro-nasal patient interface

PendingUS20160082214A1Reduction in part countIncrease patient selectionBreathing masksRespiratory masksMedicineOral cavity
A patient interface to provide breathable gas to a patient, comprising: a plenum chamber assembly, comprising: a nasal plenum chamber at least partly defining an upper gas chamber; an oral plenum chamber at least partly defining a lower gas chamber; and a decoupling structure at least partly connecting the nasal plenum chamber and the oral plenum chamber and at least party defining a flow path; a top plate including at least one connection feature configured to releasably retain a first portion of a positioning and stabilising structure; and a faceplate configured to releasably retain a second portion of a positioning and stabilising structure.
Owner:RESMED LTD

Thermoplastic film for a laminated-glass pane having a non-linear continuous wedge insert in the vertical and horizontal direction in some sections

A thermoplastic film for a laminated-glass pane, having a non-linear continuous wedge insert in both a vertical and horizontal direction in some sections, is described. In the vertical direction, the laminated-glass pane is, from the perspective of an observer, further at a lower end than at an upper end. In a laminated-glass pane equipped with the thermoplastic film, the thermoplastic film is located between two glass layers. The thermoplastic film has at least a first section having a wedge angle profile that is continuous and non-linear in the vertical and horizontal direction, such that ghost images from a head-up display are minimized in the region of the first section. The thermoplastic film also minimizes double images in transmission in the first section and in further sections.
Owner:SAINT-GOBAIN GLASS FRANCE

Novel lactic acid bacteria and compositions containing them against bacterial colds

The invention describes a microorganism of the order of lactic acid bacteria or an analogue, fragment, derivative, mutant or combination thereof, wherein the microorganism, or analogue, fragment, derivative, mutant or combination thereof can coaggregate with Streptococcus pyogenes.
Owner:ORGANOBALANCE MEDICAL AG

Copper cmp polishing pad cleaning composition comprising of amidoxime compounds

The present invention relates to methods of using amidoxime compositions for cleaning polishing pads, particularly after chemical mechanical planarization or polishing is provided. A polishing pad is cleaned of Cu CMP by-products, subsequent to or during planarizing a wafer, to reduce pad-glazing by applying to the polishing pad surface a composition comprising an aqueous amidoxime compound solution in water.
Owner:EKC TECH

Start-up procedure for an isolated switched mode power supply

An isolated switched mode power supply (SMPS) is disclosed. The SMPS comprises a switching controller to generate start-up and operational switching control signals. The SMPS further includes a transformer, having a primary winding, and a full-bridge drive circuit to drive the primary winding. The full-bridge drive circuit comprises a first switching element, a boot-strap dnving circuit, and a second switching element. The switching controller is further used to start up isolated SMPS by determining a duty cycle for operational control signals and generating the start-up switching control signals.
Owner:TELEFON AB LM ERICSSON (PUBL)

Compositions and methods of use for extracts of magnoliaceae plants

InactiveUS6582735B2Reduce and preventWithout reduction and loss of motor functionBiocideNervous disorderHonokiolMagnolol
The invention relates to compositions and methods for preventing, treating, or managing sleeplessness, restlessness, weight gain including weight gain due to stress or lack of sleep, or all three comprising the administration of a prophylactically and therapeutically effective amount of Magnoliaceae plant or extracts thereof to a mammal in need of such therapy. Preferably the mammal is human and the compositions have comprise at least two compounds selected from magnolol, honokiol, and magnoflorine. Alternatively, the compositions may also comprise about 2% honokiol by weight of the composition.
Owner:INTERHEALTH NUTRACEUTICALS

Methods and compositions that enhance bioavailability of coenzyme-Q10

Bioavailability of Coenzyme-Q10 (“Co-Q10”), an oil-soluble substance, can be enhanced in a subject by modifying, e.g. nanonizing or charging, the form of Co-Q10. Co-Q10 bioavailability also can be enhanced by administering Co-Q10 to the subject as an oil (lipid)-based and water (hydro)-based mixed composition, along with other optional components, such as oils, resins and other carriers. Accordingly, the invention provides various Co-Q10 compositions, e.g. compositions comprised of (i) Co-Q10 dissolved in one or more Co-Q10-soluble oils and (ii) Co-Q10 in admixture with at least one water-dispersible agent. A Co-Q10 complex of the invention, therefore, yields an increased cell absorption rate, as well as an enhanced percentage of Co-Q10 peak absorption, compared to previously known compounds. Methods for making and using the aforementioned compositions also are provided.
Owner:THE NATURES BOUNTY CO

Antagonists of a non-selective cation channel in neural cells

InactiveUS20100092469A1Reduce mortalityReduces stroke sizeBiocideNervous disorderDiseaseNervous system
The present invention is directed to a combination of therapeutic compounds and treatment methods and kits using the combination. In particular, one of the combination affects the NCca-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system. Exemplary SUR1 and / or TRPM4 antagonists that inhibit the NCca-ATP channel may be employed in the combination. The combination therapy also employs one or more of a non-selective cation channel blocker and / or an antagonist of VEFG, NOS, MMP, or thrombin. Exemplary indications for the combination therapy includes the prevention, diminution, and / or treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury, for example. In other embodiments, there are methods and compositions directed to antagonists of TRPM4, including at least for therapeutic treatment of traumatic brain injury, cerebral ischemia, central nervous system (CNS) damage, peripheral nervous system (PNS) damage, cerebral hypoxia, or edema, for example.
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS

Smartphone with front camera and maximized display screen

A smartphone device may have thin borders at the left, right, top, and / or bottom edges of the display screen. To accommodate, e.g., a front camera in spite of a border that is too thin for a camera module and lens, at least one corner of the display may be cut out. Optical sensor(s), emitter(s), or the lens of a front camera may be disposed at the location(s) of the cutout(s). A wide-screen movie may be displayed in letterbox mode with horizontal bars above and / or below the movie, wherein the cutout(s) are located, at least partially, in the region(s) of the horizontal bars, thereby avoiding that larger parts of the movie are hidden by the cutout(s). In other embodiments, an uninterrupted status bar may be displayed between a cutout in the upper-left corner and a cutout in the upper-right corner of the display.
Owner:INODYN NEWMEDIA

Pivotal gate for a catch basin of a storm drain system

A pivotal gate system to be installed across the drain opening to a catch basin of a storm drain system and having a catch basin blocking gate that is adapted to rotate from a closed position extending completely across the drain opening at which to trap and prevent leaves, litter and other debris from entering the catch basin during dry periods and light rainfall to an open position removed from the drain opening at which to permit rainwater to enter the catch basin during periods of heavy rainfall. A water wheel is mounted for rotation within the catch basin. The water wheel is coupled to the catch basin blocking gate by way of a pulling cable. The water wheel rotates in response to impact forces caused by rainwater dropping downwardly on a plurality of scoops extending around the water wheel. A rotation of the water wheel generates a pulling force in the pulling cable to be applied to the catch basin blocking gate whereby to cause the blocking gate to move from the closed position to the open position.
Owner:YEHUDA LEON H
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products